文献速递肾小球疾病

MicroRNA-23b-3p缺失诱导与黏膜IgA合成失调相关的IgA肾病样疾病

MicroRNA-23b-3p Deletion Induces an IgA Nephropathy-like Disease Associated with Dysregulated Mucosal IgA Synthesis.
PubMed 文献 · J Am Soc Nephrol · 2021-09-03

该研究利用CRISPR-Cas9构建miR-23b-3p敲除小鼠,发现其出现系膜IgA和C3沉积、白蛋白尿、高血压、血清肌酐升高及黏膜IgA合成失调的IgA肾病样表型。人类IgA肾病患者肾活检和血清miR-23b水平下调,且血清miR-23b与血清IgA1水平负相关。机制涉及miR-23b对黏膜B细胞中AID的抑制丧失,以及gremlin 2和转铁蛋白受体调控异常。

要点

  • miR-23b-3p敲除小鼠可复制IgA肾病样表型。
  • IgA肾病患者肾组织和血清miR-23b水平下调。
  • 血清miR-23b与血清IgA1水平呈负相关。

核心结论

  • miR-23b在肾脏疾病尤其是IgA肾病中具有不可或缺的作用,可能成为未来治疗IgA肾病的新靶点。

研究设计与样本

  • 利用CRISPR-Cas9技术构建miR-23b-3p单基因敲除小鼠。
  • 在人类中检测IgA肾病患者肾活检和血清miR-23b水平,并分析其与血清IgA1的相关性。

主要发现

  • miR-23b-/-小鼠出现系膜IgA和C3沉积,伴白蛋白尿、高血压、血清肌酐升高及黏膜IgA合成失调。
  • IgA合成失调可能由黏膜B细胞中miR-23b介导的AID抑制丧失所致。
  • miR-23b缺失通过失去对gremlin 2表达的调控增加肾脏进行性纤维化易感性,并通过下调转铁蛋白受体促进IgA积聚。
  • 人类IgA肾病患者肾活检和血清miR-23b水平下调,血清miR-23b与血清IgA1水平负相关。

临床怎么用

  • miR-23b-3p可作为IgA肾病潜在生物标志物和治疗靶点,但尚需临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: IgA nephropathy (IgAN) is the most common primary GN worldwide. Circulating immune complexes form that are prone to deposition in the mesangium, where they trigger glomerular inflammation. A growing body of evidence suggests that dysregulated expression of microRNAs in IgAN may play a significant role in establishing the disease phenotype. METHODS: We generated single miR-23b-3p(miR-23b) knockout mice using CRISPR-Cas9. RESULTS: In humans, miR-23b levels are downregulated in kidney biopsies and sera of patients with IgAN, and serum miR-23b levels are negatively correlated with serum IgA1 levels. We show that miR-23b-/- mice develop an IgAN-like phenotype of mesangial IgA and C3 deposition associated with development of albuminuria, hypertension, an elevated serum creatinine, and dysregulated mucosal IgA synthesis. Dysregulation of IgA production is likely mediated by the loss of miR-23b-mediated suppression of activation-induced cytidine deaminase in mucosal B cells. In addition, we show that loss of miR-23b increases the susceptibility of the kidney to progressive fibrosis through loss of regulation of expression of gremlin 2 and IgA accumulation through downregulation of the transferrin receptor. CONCLUSIONS: Our findings suggest an indispensable role for miR-23b in kidney disease, and in particular, IgAN. miR-23b may in the future offer a novel therapeutic target for the treatment of IgAN.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Li H, Chen Z, Chen W, et al. MicroRNA-23b-3p Deletion Induces an IgA Nephropathy-like Disease Associated with Dysregulated Mucosal IgA Synthesis. J Am Soc Nephrol. 2021. PMID: 34479967. doi:10.1681/ASN.2021010133

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。